She, RC Taggart, EW Petti, CA
She, Rosemary C. Taggart, Edward W. Petti, Cathy A.
Comparison of 10 Indirect Fluorescent Antibodies to Detect and Type Influenza A Specimens
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
23rd Annual Clinical Virology Symposium
MONOCLONAL-ANTIBODIES; RAPID INFLUENZA; MULTIPLEX PCR; UNITED-STATES; B VIRUSES; MANAGEMENT; SUBTYPES; IDENTIFICATION; SPECIFICITY; DIAGNOSIS
Context.-Management of influenza infections relies on rapid, accurate, and sensitive diagnostic techniques. Influenza A (IA) strain typing has become more important since the emergence of highly pathogenic avian and novel influenza strains and the high frequency of oseltamivir resistance in circulating H1N1 isolates. Objective.-To analyze the performance of indirect fluorescent antibody testing for subtyping a broad range of IA strains. Design.-Ten indirect fluorescent antibody reagents were used to detect and type 100 archived IA respiratory specimens from 1986 through 1995 and 2006 through 2007 and a reassortant, nonpathogenic H5N1 sample. Both direct specimen and cultured isolates were tested. Reverse transcription-polymerase chain reaction was used to confirm indirect fluorescent antibody results. Three H1N1-, 2 H3N2-, and 1 H1-H2-H3-H5-specific antibodies (Chemicon Diagnostics), an IA pool reagent (Trinity Biotech), and H1, H3, and H1-H3-specific antibodies (Centers for Disease Control and Prevention) were used. Results.-Reverse transcription-polymerase chain reaction confirmed all 100 isolates as IA and identified 71 as H1, 22 as H3, and 7 as non-H1-H3. Sensitivity of direct specimen testing ranged was 18.3% to 57.7% for the H1 reagents, 36.4% to 50.0% for the H3 reagents, and 40.0% to 53.8% for the pool reagents. Subtyping was more sensitive on cultured isolates than direct specimens. Specificity for all antibodies was 89.7% to 100%. The H5N1 sample was positive by direct testing and culture (reverse transcription-polymerase chain reaction, Centers for Disease Control and Prevention H5N1 pool, Chemicon H1-H2-H3-H5). No cross-reactivity was observed when the 10 antibodies were tested against other common respiratory viruses. Conclusions.-When positive, IA subtyping antibodies can serve as a useful diagnostic tool when multiple influenza virus subtypes are cocirculating with different susceptibility patterns. (Arch Pathol Lab Med. 2010; 134: 1177-1180)
1 [She, Rosemary C.; Petti, Cathy A.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84108 USA. [Petti, Cathy A.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84108 USA. [She, Rosemary C.; Taggart, Edward W.; Petti, Cathy A.] Associated Reg & Univ Pathologists Labs, Salt Lake City, UT USA.
She, RC, Univ Utah, Sch Med, Dept Pathol, 500 Chipeta Way, Salt Lake City, UT 84108 USA.
ALVAREZ AC, 2008, VIROL J, V5, ARTN 77 BHAVNANI D, 2007, INT J INFECT DIS, V11, P355, DOI 10.1016/j.ijid.2006.09.009 BRAMMER L, 2008, MMWR-MORBID MORTAL W, V57, P1046 BRAMMER L, 2009, MMWR-MORBID MORTAL W, V58, P115 FALSEY AR, 2007, ARCH INTERN MED, V167, P354 JENNINGS LC, 2009, INFLUENZA OTHER RESP, V3, P91, DOI 10.1111/j.1750-2659.2009.00079.x MAHONY J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06 NOYOLA DE, 2000, PEDIATR INFECT DIS J, V19, P303 SCHMIDT NJ, 1982, J CLIN MICROBIOL, V16, P763 STEVENS J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016 STOCKTON J, 1998, J CLIN MICROBIOL, V36, P2990 TKACOVA M, 1997, J CLIN MICROBIOL, V35, P1196 UEDA M, 1998, J CLIN MICROBIOL, V36, P340 VARECKOVA E, 2002, J CLIN MICROBIOL, V40, P2220 VARECKOVA E, 2008, VIRUS RES, V132, P181, DOI 10.1016/j.virusres.2007.10.004 WALLS HH, 1986, J CLIN MICROBIOL, V23, P240 WRIGHT KE, 1995, J CLIN MICROBIOL, V33, P1180 ZIEGLER T, 1995, J CLIN MICROBIOL, V33, P318
COLLEGE AMER PATHOLOGISTS
C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
Arch. Pathol. Lab. Med.
Medical Laboratory Technology; Medicine, Research & Experimental; Pathology